The Science and Technology
PGxHealth, a division of Clinical Data, Inc. is committed to leveraging pharmacogenomics (PGx™) and its capabilities in genetic marker identification and validation, to develop and commercialize novel genetic tests leading to safer and more efficacious therapeutics. PGxHealth utilizes its expertise and established infrastructure to discover genetic markers and in-license others that form the foundation of these genetic tests. These tests are targeted to assist healthcare providers in determining the most efficacious and safe treatment for their patients. Advances in biomarker identification, pharmacogenomics, laboratory practices and the clinic, have set the stage for the use of genetic biomarkers to create what we have branded Therapeutic Diagnostics™. |
| |
Improved Care, Better Outcomes
PGxHealth’s ultimate objective is to provide genetic tests that assist healthcare providers in determining the most efficacious and safe therapies for their patients as well as, in some instances, propensity for developing a given disease. By employing genetic testing in the practice of care, we expect to:
- Positively impact costs related to the use of therapeutics and the delivery of medical care
- Increase efficacy of treatment
- Improve patient safety
- Improve patient care and quality of life
PGxHealth has a seasoned management team with a deep understanding of medical care delivery, the financial dynamics in healthcare as well as the value propositions for healthcare’s key constituents, and the link between the science of genomics and its clinical utility. The Company is focused on maximizing value for these constituents through the introduction of Therapeutic Diagnostics into the care delivery equation.
|
|
| |
|
|
 |
| |
|
|
|
| |
 |
|
 |
| |
|
|
|
| |
 |
|
 |
| |
|
|
|
| |
Customer Service
1-877-2-PGXHEALTH (877-274-9432)
|
|
